Analytical Data
-
基因名
GGTLA4
- Application
-
别名
dJ831C21.1; dJ831C21.2; Gamma glutamyl transpeptidase; Gamma glutamyltransferase-like activity 3; Gamma-glutamyltransferase light chain 1; Gamma-glutamyltransferase-like activity 4; Gamma-glutamyltransferase-like protein 6; GGTL1_HUMAN; GGTL6; GGTLA3; GGTLA4; GGTLC1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BX51
-
表达区间
1-225aa
-
氨基酸序列
MTSEFFSAQLRAQISDDTTHPISYYKPEFYMPDDGGTAHLSVVAEDGSAVSATSTINLYFGSKVRSPVSGILLNNEMDDFSSTSITNEFGVPPSPANFIQPGKQPLSSMCPTIMVGQDGQVRMVVGAAGGTQITMATALAIIYNLWFGYDVKWAVEEPRLHNQLLPNVTTVERNIDQEVTAALETRHHHTQITSTFIAVVQAIVRMAGGWAAASDSRKGGEPAGY
-
分子量
50.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GGTLA4, short for "Glycosylated Glypican-4-Like Protein 4," has emerged as a focal point in contemporary biomedical research due to its potential implications in various physiological and pathological processes. Initially discovered as a member of the glypican family, GGTLA4 is believed to play a crucial role in cell signaling pathways, influencing cell development, proliferation, and differentiation. Its expression is particularly notable in the nervous system, raising questions about its involvement in neurodevelopmental disorders and neural regeneration. Recent studies have suggested that GGTLA4 may interact with key signaling molecules and may have implications in cancer biology, particularly in tumor growth and metastasis. The recombinant protein form of GGTLA4 has been produced to facilitate detailed investigations into its structure-function relationships and physiological roles. By generating the recombinant protein, researchers aim to elucidate the mechanisms by which GGTLA4 exerts its biological functions, identify potential therapeutic targets, and explore its utility in diagnostics. Additionally, GGTLA4 is also under examination for its participation in glycan-mediated cell interactions, making it a significant candidate for further exploration in tissue engineering and regenerative medicine. As our understanding of GGTLA4 expands, its potential applications in targeted therapies and as a biomarker for disease continue to be areas of significant interest within the scientific community.
